Fusion Pharmaceuticals Inc logo

FUSN - Fusion Pharmaceuticals Inc News Story

$8.51 0.3  3.7%

Last Trade - 9:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £250.8m
Enterprise Value £87.3m
Revenue £n/a
Position in Universe 4090th / 7008

BRIEF-Fusion Pharmaceuticals Announces Clinical Collaboration With Merck

Thu 6th May, 2021 1:21pm
May 6 (Reuters) - Fusion Pharmaceuticals Inc  FUSN.O :
    * FUSION PHARMACEUTICALS ANNOUNCES CLINICAL COLLABORATION
WITH
MERCK TO EVALUATE FUSION'S TARGETED ALPHA THERAPY (TAT) IN
COMBINATION WITH MERCK'S KEYTRUDA® (PEMBROLIZUMAB) IN PATIENTS
WITH SOLID TUMORS EXPRESSING IGF-1R

Source text for Eikon:  ID:nCNWgQSfGa 
Further company coverage:  FUSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.